title: Plasmodium knowlesi: the emerging zoonotic malaria parasite.
abstract: Plasmodium knowlesi was initially identified in the 30s as a natural Plasmodium of Macaca fascicularis monkey also capable of experimentally infecting humans. It gained a relative notoriety in the mid-30s as an alternative to Plasmodium vivax in the treatment of the general paralysis of the insane (neurosyphilis). In 1965 the first natural human infection was described in a US military surveyor coming back from the Pahang jungle of the Malaysian peninsula. P. knowlesi was again brought to the attention of the medical community when in 2004, Balbir Singh and his co-workers reported that about 58% of malaria cases observed in the Kapit district of the Malaysian Borneo were actually caused by P. knowlesi. In the following years several reports showed that P. knowlesi is much more widespread than initially thought with cases reported across Southeast Asia. This infection should also be considered in the differential diagnosis of any febrile travellers coming back from a recent travel to forested areas of Southeast Asia. P. knowlesi can cause severe malaria with a rate of 6-9% and with a case fatality rate of 3%. Respiratory distress, acute renal failure, shock and hyperbilirubinemia are the most frequently observed complications of severe P. knowlesi malaria. Chloroquine is considered the treatment of choice of uncomplicated malaria caused by P. knowlesi.
authors.affiliation: Department of Biomedical and Clinical Sciences Luigi Sacco, III Division of Infectious Diseases Luigi Sacco Hospital, Università degli Studi di Milano, Italy. spinello.antinori@unimi.it
authors.forename: Spinello
authors.initials: S
authors.lastname: Antinori
authors.forename: Laura
authors.initials: L
authors.lastname: Galimberti
authors.forename: Laura
authors.initials: L
authors.lastname: Milazzo
authors.forename: Mario
authors.initials: M
authors.lastname: Corbellino
mesh_terms: D000818:Animals; D000852:Anopheles / Q000469:parasitology; D000962:Antimalarials / Q000494:pharmacology; D001893:Borneo / Q000453:epidemiology; D002738:Chloroquine / Q000494:pharmacology; D021821:Communicable Diseases, Emerging / Q000469:parasitology; D005843:Geography; D006801:Humans; D007303:Insect Vectors / Q000469:parasitology*; D008288:Malaria / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000469:parasitology*; D016790:Plasmodium knowlesi / Q000472:pathogenicity*; D013921:Thrombocytopenia / Q000469:parasitology / Q000473:pathology; D014195:Travel; D053058:Trophozoites / Q000254:growth & development; D015047:Zoonoses / Q000469:parasitology* / Q000635:transmission
chemical_list: D000962:Antimalarials; D002738:Chloroquine